BIOLOGICAL SUBSTANCES

Brand	Owner (click to sort)	Address	Description
100 BILLION HIGH POTENTIALS	MorphoSys AG	Semmelweisstrasse 7 Planegg 82152 Germany	Biological substances, namely, antibodies and fragments of antibodies for human medical diagnostics and analysis; pharmaceutical preparations, namely, antibodies and fragments of antibodies for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis and for use in laboratories, diagnostics, and analytics [; sanitary preparations for medical use ];Chemical, biochemical, biological and biotechnological preparations, namely, antibodies and fragments of antibodies for use in the development or manufacture of immunological reagents used in industry and science; biological preparations, namely, antibodies and fragments of antibodies for laboratories, for diagnostics, and for analysis [ and environmental analysis ] [; chemical, biochemical, biological and biotechnological additives, namely, auxiliary agents, carriers and substances for use in the manufacture of pharmaceutical preparations ];[ Scientific, biological, pharmaceutical and medical research services; laboratory research in the field of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; ]chemical, biochemical and biotechnological analysis;
BISSIG	MorphoSys AG	Semmelweisstrasse 7 Planegg 82152 Germany	Biological substances, namely, antibodies and fragments of antibodies for human medical diagnostics and analysis; pharmaceutical preparations and substances, namely, antibodies and fragments of antibodies for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis and for use in laboratories, diagnostics, and analytics; sanitary preparations for medical use;Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations; biological preparations, namely, antibodies and fragments of antibodies for laboratories, for diagnostics, and for analysis and environmental analysis; auxiliary agents, carriers and substances for use in the manufacture of pharmaceutical preparations;The English translation of BISSIG in the mark is snappy or biting.;Scientific, biological, pharmaceutical and medical research services; laboratory research in the field of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; chemical, biochemical and biotechnological analysis;
FIFTY BILLION HIGH POTENTIALS	MorphoSys AG	Semmelweisstrasse 7 Planegg 82152 Germany	biological substances, namely, antibodies and fragments of antibodies for human medical diagnostics and analysis; pharmaceutical preparations, namely, antibodies and fragments of antibodies for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use;chemical, biochemical, biological and biotechnological preparations, namely, antibodies and fragments of antibodies for use in the development or manufacture of immunological reagents used in industry and science; biological preparations, namely, antibodies and fragments of antibodies for laboratories, diagnostics and analytics for scientific or research use;Scientific, biological, pharmaceutical and medical research services; laboratory research in the field of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; chemical, biochemical and biotechnological analysis;
GS KNOCKOUT	LONZA LTD.	Lonzastrasse Visp 3930 Switzerland	Biological substances, in particular manipulated cells and vectors for the production of human, animal and synthetic proteins for clinical and commercial purposes for human and animal therapeutics;GS KNOCK OUT;Biological substances, in particular manipulated cells and vectors for the production of human, animal and synthetic proteins, for scientific research, pharmaceutical research and clinical and commercial use;
NANOPLASMID	Nature Technology Corp.	4701 Innovation Drive Suite 103 Lincoln NE 68521	Biological substances, materials, and preparations for manufacture and development of gene therapy products, pharmaceuticals, biopharmaceuticals, and vaccines; cloning vectors, expression vectors and reagents for clinical or research use; pharmaceutical preparations for detecting or treating genetic predispositions for medical purposes;
PEPIG	MorphoSys AG	Semmelweisstrasse 7 Planegg 82152 Germany	Biological substances, namely, antibodies and fragments of antibodies for human medical diagnostics and analysis; pharmaceutical preparations and substances, namely, antibodies and fragments of antibodies for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use;Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations; Biological preparations, namely, antibodies and fragments of antibodies for clinical or medical laboratory use, for scientific or research diagnostic use, and for scientific and environmental analysis; auxiliary agents, carriers and substances in the nature of chemicals for use in the manufacture of pharmaceutical preparations;Scientific, biological, pharmaceutical and medical research services; laboratory research in the field of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; laboratory analysis in the chemical, biochemical and biotechnological fields;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

(Beauveria) sp. FO-6979 (FERM BP-6681), which belongs to the genus Beauveria and is capable of producing FO-6979-M0, -M1, -M2, -M3 and -M4 substances, is cultured in a medium to thereby accumulate the FO-6979-M0, -M1, -M2, -M3 and -M4 substances in the liquid culture medium. Then the FO-6979-M0, -M1, -M2, -M3 and -M4 substances are collected from the culture medium. The substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit the formation of oil droplets in macrophages. Owing to these characteristics, the above substances are useful in preventing and treating human diseases caused by cholesterol accumulation.